Globeflex Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Globeflex Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$912K	Buy	+259,809	New	+$1.06M	0.14%	166
2023 Q1	–	Sell	-121,452	Closed	-$1.5M	–	493
2022 Q4	$1.5M	Sell	121,452 -35,174	-22%	-$399K	0.19%	129
2022 Q3	$1.62M	Buy	156,626 +47,386	+43%	+$537K	0.28%	106
2022 Q2	$1.26M	Hold	109,240	–	–	0.31%	89
2022 Q1	$1.37M	Hold	109,240	–	–	0.28%	97
2021 Q4	$1.27M	Hold	109,240	–	–	0.26%	117
2021 Q3	$1.43M	Buy	109,240 +37,625	+53%	+$486K	0.31%	86
2021 Q2	$922K	Buy	71,615 +121	+0.2%	+$1.39K	0.17%	203
2021 Q1	$799K	Hold	71,494	–	–	0.15%	226
2020 Q4	$814K	Buy	71,494 +17,144	+32%	+$188K	0.17%	196
2020 Q3	$489K	Hold	54,350	–	–	0.13%	255
2020 Q2	$561K	Hold	54,350	–	–	0.14%	246
2020 Q1	$548K	Buy	54,350 +10,534	+24%	+$124K	0.17%	210
2019 Q4	$583K	Buy	+43,816	New	+$483K	0.11%	292
2015 Q2	–	Sell	-92,367	Closed	-$1.24M	–	541
2015 Q1	$1.24M	Buy	+92,367	New	+$1.21M	0.24%	166

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Globeflex Capital's IRWD Position: Q1 2026 in Review

Globeflex Capital opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 259,809 shares worth $912K. The stake represents 0.14% of the portfolio and ranks #166 among its holdings. This is a return to the name: Globeflex Capital previously reported a position in IRWD as recently as Q4 2022.

Globeflex Capital first reported a position in IRWD in Q1 2015 and has held it in 15 quarters since. The position peaked at $1.62M in Q3 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Globeflex Capital held 259,809 shares of Ironwood Pharmaceuticals worth $912K as of Q1 2026.
Ironwood Pharmaceuticals was a new Globeflex Capital position in Q1 2026.
Ironwood Pharmaceuticals made up 0.14% of Globeflex Capital's portfolio in Q1 2026, its #166 holding.
Globeflex Capital first reported a position in Ironwood Pharmaceuticals in Q1 2015 and has held it in 15 quarters since.
Globeflex Capital's Ironwood Pharmaceuticals position peaked at $1.62M in Q3 2022.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.